A recent study has shed light on the potential risks associated with higher doses of the fertility drug clomiphene citrate, commonly used in IVF treatments. The findings indicate that while the drug is intended to increase the chances of pregnancy, higher cumulative doses may actually lead to adverse outcomes.
Key Insights
The study, which analyzed data from over 21,000 IVF embryo transfer cycles in the United States, identified a dose-response relationship where higher doses of clomiphene citrate were associated with increased risks of miscarriage, stillbirth, and multiple births, without a significant improvement in the chance of a live birth.










